Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Suction Retractor Eases Access to the Cervix

By HospiMedica International staff writers
Posted on 10 Feb 2015
A new suction cervical retractor provides an intuitive and reliable tool for diagnostic and therapeutic gynecological procedures.

The Bioceptive suction cervical retractor is a non-traumatic device that uses gentle suction to engage at 360 degrees around the cervix, creating a functional portal through which a variety of instruments can be passed into the cervical canal and uterus. More...
The retractor can be used in a wide range of gynecological procedures, including endometrial biopsies, intrauterine device (IUD) insertion, fertility procedures, and others. It is suitable for use with numerous instruments and from various manufacturers.

The suction cervical retractor replaces standard cervical tenaculum forceps, which are used to pierce and clamp cervical tissue to stabilize the cervix and uterus. The retractor, a product of Bioceptive (New Orleans, LA, USA), will also serve as a future platform for a pipeline of other products currently under development, some of them in preclinical testing. One such device is a comprehensive insertion system for IUDs that is intended to replace the four to five instruments currently used in such procedures.

“Bioceptive’s suction tenaculum is a truly novel gynecologic instrument that permits cervical traction without tissue penetration,” said David Turok, MD, MPH, an associate professor of obstetrics and gynecology at the University of Utah (Salt Lake City, USA). “This device coupled with Bioceptive’s IUD inserter has the potential to revolutionize IUD insertion by dramatically simplifying the process.”

An IUD is a small, long-acting reversible contraception device, often 'T'-shaped, which is inserted into the uterus; it usually contains either copper or levonorgestrel. The IUD works primarily by preventing fertilization, as the progestogen released thickens the cervical mucus so that sperm cannot reach the fallopian tubes. Copper IUDs contain no hormones, but the copper ions in the cervical mucus are toxic to sperm. They also cause the uterus and fallopian tubes to produce a fluid that contains white blood cells, copper ions, enzymes, and prostaglandins, a combination that is also toxic to sperm. The IUD is one of the more effective types of reversible birth control, with failure rates of copper IUDs at about 0.8%, while the levonorgestrel IUD has a failure rate of 0.2% in the first year of use.

Related Links:

Bioceptive 



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.